These results are consistent with the previous study and indicate that PERK/ATF4/SIAH2/HIPK2 might be the molecular mechanism of TMP to maintain the function of pulmonary artery vascular and to inhibit the development of PAH. The gene discussed is SIAH2; the disease is pulmonary arterial hypertension.